Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran; Nadine Landolina; Pratibha Gaur; Tihana Lenac Rovis; Stipan Jonjic; Ofer Mandelboim; Bernhard B. Singer; Francesca Levi-Schaffer

doi:10.1038/s41417-023-00594-2

Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Ilan Zaffran, Nadine Landolina, Pratibha Gaur, Tihana Lenac Rovis, Stipan Jonjic, Ofer Mandelboim, Bernhard B. Singer, Francesca Levi-Schaffer

The Hebrew University of Jerusalem

Research output: Contribution to journal › Comment/debate

Abstract

In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

Original language	English
Pages (from-to)	926
Number of pages	1
Journal	Cancer Gene Therapy
Volume	30
Issue number	6
DOIs	https://doi.org/10.1038/s41417-023-00594-2
State	Published - Jun 2023

All Science Journal Classification (ASJC) codes

Molecular Medicine
Molecular Biology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41417-023-00594-2

Cite this

Zaffran, I., Landolina, N., Gaur, P., Rovis, T. L., Jonjic, S., Mandelboim, O., Singer, B. B., & Levi-Schaffer, F. (2023). Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x). Cancer Gene Therapy, 30(6), 926. https://doi.org/10.1038/s41417-023-00594-2

@article{695e1787379844428313e7a3f1aef766,

title = "Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)",

abstract = "In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.",

author = "Ilan Zaffran and Nadine Landolina and Pratibha Gaur and Rovis, {Tihana Lenac} and Stipan Jonjic and Ofer Mandelboim and Singer, {Bernhard B.} and Francesca Levi-Schaffer",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s), under exclusive licence to Springer Nature America, Inc.",

year = "2023",

month = jun,

doi = "10.1038/s41417-023-00594-2",

language = "الإنجليزيّة",

volume = "30",

pages = "926",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Springer Nature",

number = "6",

}

Zaffran, I, Landolina, N, Gaur, P, Rovis, TL, Jonjic, S, Mandelboim, O, Singer, BB & Levi-Schaffer, F 2023, 'Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)', Cancer Gene Therapy, vol. 30, no. 6, pp. 926. https://doi.org/10.1038/s41417-023-00594-2

TY - JOUR

T1 - Correction to

T2 - Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

AU - Zaffran, Ilan

AU - Landolina, Nadine

AU - Gaur, Pratibha

AU - Rovis, Tihana Lenac

AU - Jonjic, Stipan

AU - Mandelboim, Ofer

AU - Singer, Bernhard B.

AU - Levi-Schaffer, Francesca

PY - 2023/6

Y1 - 2023/6

N2 - In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

AB - In this article the author name Stipan Jonjic was incorrectly written as Jonjic Stipan. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85147375658&partnerID=8YFLogxK

U2 - 10.1038/s41417-023-00594-2

DO - 10.1038/s41417-023-00594-2

M3 - تعليقَ / نقاش

C2 - 36732550

SN - 0929-1903

VL - 30

SP - 926

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 6

ER -

Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (Cancer Gene Therapy, (2022), 29, 11, (1676-1685), 10.1038/s41417-022-00486-x)

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this